
### [NCIT:C3908](http://purl.obolibrary.org/obo/NCIT_C3908)
**Label:** Ampulla of Vater Carcinoma

**Subclasses:** [NCIT:C134872](http://purl.obolibrary.org/obo/NCIT_C134872) (Stage III Ampulla of Vater Cancer AJCC v8), [NCIT:C6655](http://purl.obolibrary.org/obo/NCIT_C6655) (Ampulla of Vater Small Cell Neuroendocrine Carcinoma), [NCIT:C6654](http://purl.obolibrary.org/obo/NCIT_C6654) (Stage IV Ampulla of Vater Cancer AJCC v7), [NCIT:C134875](http://purl.obolibrary.org/obo/NCIT_C134875) (Stage IV Ampulla of Vater Cancer AJCC v8), [NCIT:C6656](http://purl.obolibrary.org/obo/NCIT_C6656) (Ampulla of Vater Signet Ring Cell Carcinoma), [NCIT:C27418](http://purl.obolibrary.org/obo/NCIT_C27418) (Ampulla of Vater Adenosquamous Carcinoma), [NCIT:C6651](http://purl.obolibrary.org/obo/NCIT_C6651) (Stage I Ampulla of Vater Cancer AJCC v7), [NCIT:C27417](http://purl.obolibrary.org/obo/NCIT_C27417) (Ampulla of Vater Squamous Cell Carcinoma), [NCIT:C6650](http://purl.obolibrary.org/obo/NCIT_C6650) (Ampulla of Vater Adenocarcinoma), [NCIT:C6653](http://purl.obolibrary.org/obo/NCIT_C6653) (Stage III Ampulla of Vater Cancer AJCC v7), [NCIT:C27419](http://purl.obolibrary.org/obo/NCIT_C27419) (Ampulla of Vater Undifferentiated Carcinoma), [NCIT:C6652](http://purl.obolibrary.org/obo/NCIT_C6652) (Stage II Ampulla of Vater Cancer AJCC v7), [NCIT:C27414](http://purl.obolibrary.org/obo/NCIT_C27414) (Ampulla of Vater Clear Cell Adenocarcinoma), [NCIT:C27416](http://purl.obolibrary.org/obo/NCIT_C27416) (Ampulla of Vater Mucinous Adenocarcinoma), [NCIT:C95967](http://purl.obolibrary.org/obo/NCIT_C95967) (Ampulla of Vater Invasive Papillary Adenocarcinoma), [NCIT:C95966](http://purl.obolibrary.org/obo/NCIT_C95966) (Ampulla of Vater Hepatoid Adenocarcinoma), [NCIT:C95965](http://purl.obolibrary.org/obo/NCIT_C95965) (Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells), [NCIT:C95986](http://purl.obolibrary.org/obo/NCIT_C95986) (Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma), [NCIT:C95985](http://purl.obolibrary.org/obo/NCIT_C95985) (Ampulla of Vater Large Cell Neuroendocrine Carcinoma), [NCIT:C95984](http://purl.obolibrary.org/obo/NCIT_C95984) (Ampulla of Vater Neuroendocrine Carcinoma), [NCIT:C134866](http://purl.obolibrary.org/obo/NCIT_C134866) (Stage I Ampulla of Vater Cancer AJCC v8), [NCIT:C134865](http://purl.obolibrary.org/obo/NCIT_C134865) (Stage 0 Ampulla of Vater Cancer AJCC v8), [NCIT:C4444](http://purl.obolibrary.org/obo/NCIT_C4444) (Stage 0 Ampulla of Vater Cancer AJCC v7), [NCIT:C134864](http://purl.obolibrary.org/obo/NCIT_C134864) (Ampulla of Vater Cancer by AJCC v8 Stage), [NCIT:C134863](http://purl.obolibrary.org/obo/NCIT_C134863) (Ampulla of Vater Cancer by AJCC v7 Stage), [NCIT:C134869](http://purl.obolibrary.org/obo/NCIT_C134869) (Stage II Ampulla of Vater Cancer AJCC v8), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 39.52%


